Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | VEGF | 823.0 | 67 | |
| N2586 | Leptin | 1 | ng/mL | 3 | VEGF | 1455.0 | 81 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | VEGF | 1126.0 | 65 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | VEGF | 1132.0 | 71 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | VEGF | 1214.0 | 66 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | VEGF | 1816.0 | 72 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | VEGF | 1418.0 | 51 | |
| RA2159 | Adiponectin | 5 | ng/mL | 3 | VEGF | 691.5 | 60 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 855.0 | 73 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 736.0 | 67 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 824.0 | 59 | |
| RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 709.5 | 60 | |
| RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 673.0 | 74 | |
| N2586 | Adiponectin | 5 | ng/mL | 3 | VEGF | 1538.0 | 55 | ||||
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 1087.0 | 70 | |
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 921.0 | 61 | |
| N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 1115.0 | 71 | |
| N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 1562.5 | 56 | |
| N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | VEGF | 1158.0 | 67 | |
| RA2159 | IGF-I | 100 | ug/mL | 3 | VEGF | 1074.0 | 55 | ||||
| RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | VEGF | 1098.0 | 51 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | VEGF | 898.0 | 59 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | VEGF | 1041.0 | 62 | |
| RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | VEGF | 851.0 | 81 | |
| RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | VEGF | 653.0 | 67 |